We are live on ! Find out more
UFF

USA Financial Formulas Portfolio holdings

AUM $531M
1-Year Est. Return 28.6%
This Fund
S&P 500
This Quarter Est. Return
+25.51%
1 Year Est. Return
+28.6%
3 Year Est. Return
+77.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
-$22.4M
Cap. Flow
-$46.8M
Cap. Flow %
-34.82%
Top 10 Hldgs %
38.49%
Holding
350
New
112
Increased
40
Reduced
54
Closed
93

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$4.38M
2
MNST icon
Monster Beverage
MNST
+$3.92M
3
DXCM icon
DexCom
DXCM
+$3M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$2.59M
5
EA icon
Electronic Arts
EA
+$2.27M

Top Sells

Rank Stock Value
1
ANSS
Ansys
ANSS
+$3.85M
2
AMAT icon
Applied Materials
AMAT
+$3.56M
3
LRCX icon
Lam Research
LRCX
+$3.54M
4
BIIB icon
Biogen
BIIB
+$3.49M
5
FISV
Fiserv Inc
FISV
+$3.35M

Sector Composition

Rank Sector Weight
1 Healthcare 29.17%
2 Technology 24.33%
3 Communication Services 15.05%
4 Consumer Staples 8.01%
5 Real Estate 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.41T
$7.68M 5.71%
37,717
-2,179
-5% -$396K
AAPL icon
2
Apple
AAPL
$4.44T
$7.67M 5.7%
84,084
-6,784
-7% -$526K
NVDA icon
3
NVIDIA
NVDA
$4.75T
$5.05M 3.75%
531,360
-52,360
-9% -$424K
EA icon
4
Electronic Arts
EA
$53B
$4.7M 3.49%
35,597
+19,202
+117% +$2.27M
REGN icon
5
Regeneron Pharmaceuticals
REGN
$76.2B
$4.54M 3.38%
7,286
-174
-2% -$98.8K
ATVI
6
DELISTED
Activision Blizzard
ATVI
$4.53M 3.37%
59,719
-5,522
-8% -$385K
DXCM icon
7
DexCom
DXCM
$31.8B
$4.49M 3.34%
44,284
+33,576
+314% +$3M
VRTX icon
8
Vertex Pharmaceuticals
VRTX
$120B
$4.46M 3.32%
15,365
+696
+5% +$189K
TMUS icon
9
T-Mobile US
TMUS
$185B
$4.34M 3.23%
41,704
+798
+2% +$76.5K
META icon
10
Meta Platforms (Facebook)
META
$1.39T
$4.33M 3.22%
19,080
+9,202
+93% +$1.92M
JNJ icon
11
Johnson & Johnson
JNJ
$622B
$4.23M 3.14%
+30,087
New +$4.38M
MNST icon
12
Monster Beverage
MNST
$94.6B
$4.16M 3.09%
+119,940
New +$3.92M
AMD icon
13
Advanced Micro Devices
AMD
$796B
$4.09M 3.04%
77,779
-1,277
-2% -$67.7K
CHTR icon
14
Charter Communications
CHTR
$17.3B
$3.85M 2.86%
7,540
-688
-8% -$349K
BMRN icon
15
BioMarin Pharmaceuticals
BMRN
$11.5B
$3.22M 2.39%
+26,075
New +$2.59M
NTES icon
16
NetEase
NTES
$84.9B
$2.69M 2%
31,350
+2,580
+9% +$194K
JD icon
17
JD.com
JD
$44.3B
$2.5M 1.86%
+41,527
New +$2.1M
LLY icon
18
Eli Lilly
LLY
$1.02T
$2.31M 1.71%
14,042
+14,039
+467,967% +$2.15M
AKAM icon
19
Akamai
AKAM
$16.5B
$2.12M 1.57%
19,758
+19,725
+59,773% +$1.98M
EQIX icon
20
Equinix
EQIX
$102B
$2.07M 1.54%
2,950
-324
-10% -$219K
COR icon
21
Cencora
COR
$60.6B
$2.01M 1.5%
+19,962
New +$1.84M
IAU icon
22
iShares Gold Trust
IAU
$62.8B
$2M 1.49%
59,008
-8,130
-12% -$266K
LQD icon
23
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.2B
$2M 1.49%
14,872
-482
-3% -$62.7K
KR icon
24
Kroger
KR
$35.6B
$1.99M 1.48%
58,841
+11,410
+24% +$370K
EFX icon
25
Equifax
EFX
$20.3B
$1.98M 1.47%
+11,499
New +$1.7M
1
2 3 4 5

Similar funds

EPA
Element Pointe Advisors Miami, Florida $530M AUM 16.87% 1-Year Est. Return
TM
Taproot Management New York $530M AUM
KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
PWS
Proactive Wealth Strategies Marietta, Georgia $532M AUM 21.29% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
SLC
Second Line Capital Metairie, Louisiana $528M AUM 16.68% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $534M AUM 22.94% 1-Year Est. Return

USA Financial Formulas's Q2 2020 Portfolio in Review

As of Q2 2020, USA Financial Formulas held 350 positions worth $135M, down 14% from $157M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

USA Financial Formulas withdrew a net $46.8M in Q2 2020, closing 93 positions and reducing 54 holdings. Its most notable exit was Gilead Sciences, an estimated $3.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 15% a quarter earlier, followed by Technology and Communication Services.

Against the trend, USA Financial Formulas opened a new position in Johnson & Johnson worth $4.23M.

  • USA Financial Formulas's largest Q2 2020 buy was Johnson & Johnson: 30,087 shares worth $4.23M.
  • USA Financial Formulas added most to DexCom in Q2 2020, an estimated $3M increase.
  • USA Financial Formulas's biggest Q2 2020 reduction was Ansys, cutting an estimated $3.85M.
  • USA Financial Formulas fully exited Gilead Sciences in Q2 2020, selling an estimated $3.34M.
  • USA Financial Formulas's ten largest holdings make up 38% of its $135M portfolio in Q2 2020.
  • USA Financial Formulas opened 112 new positions and closed 93 in Q2 2020.
  • USA Financial Formulas's portfolio value fell 14% quarter-over-quarter to $135M.

Based on USA Financial Formulas's 13F filing for Q2 2020, filed 11 Aug 2020.